Below are the most recent publications written about "Receptors, Progesterone" by people in Profiles.
-
Xia K, Chen E, Hu R, Pagano I, Fukui J. Applicability of Oncotype DX Testing in a Diverse Breast Cancer Population in Hawaii. Breast J. 2025; 2025:9104103.
-
Wolf DM, Yau C, Campbell M, Glas A, Barcaru A, Mittempergher L, Kuilman M, Brown-Swigart L, Hirst G, Basu A, Magbanua M, Sayaman R, Huppert L, Delson A, Symmans WF, Borowsky A, Pohlmann P, Rugo H, Clark A, Yee D, DeMichele A, Perlmutter J, Petricoin EF, Chien J, Stringer-Reasor E, Shatsky R, Liu M, Han H, Soliman H, Isaacs C, Nanda R, Hylton N, Pusztai L, Esserman L, van 't Veer L. Immune Subtyping Identifies Patients With Hormone Receptor-Positive Early-Stage Breast Cancer Who Respond to Neoadjuvant Immunotherapy (IO): Results From Five IO Arms of the I-SPY2 Trial. JCO Precis Oncol. 2025 Jun; 9:e2400776.
-
Fu Z, Borho L, Taylor SE, Kelemen LE, DeFazio A, Webb PM, K?bel M, Meagher NS, Na R, Antoniou AC, Brand AH, Kennedy CJ, Nevins N, Pharoah PDP, Shvetsov YB, Winham SJ, Alsop J, Beckmann MW, Bolithon A, Boros J, Bowtell DDL, Brenton JD, Carney ME, Chudecka-Glaz A, Cook LS, Cybulski C, Fasching PA, Fereday S, Fortner RT, Garc?a MJ, Goode EL, Goodman MT, Gronwald J, Hartmann A, Hernandez BY, H?gdall E, Huntsman DG, Jensen A, Jimenez-Linan M, Joseph JM, Karlan BY, Kaznowska E, Kjaer SK, Kluz T, Koziak JM, Lester J, Longacre TA, Lycke M, McGuire V, Moysich KB, Murphy RA, Orsulic S, Ramus SJ, Rodr?guez-Antona C, Rothstein JH, Samra S, Sieh W, Steed H, Sundfeldt K, Talhouk A, Ucinski J, Wang C, Wentzensen N, Whittemore AS, Wilkens LR, Songer T, Brooks MM, Tang L, Modugno F. Ovarian cancer risk and survival according to tumor sex hormone receptor expression: An ovarian Cancer association consortium and ovarian tumor tissue analysis consortium pooled analysis. Gynecol Oncol. 2025 Jul; 198:112-129.
-
Abou-Fadel J, Jiang X, Grajeda B, Padarti A, Ellis CC, Flores E, Cailing-De La O AD, Zhang J. CCM signaling complex (CSC) couples both classic and non-classic Progesterone receptor signaling. Cell Commun Signal. 2022 08 15; 20(1):120.
-
Zavala VA, Casavilca-Zambrano S, Navarro-V?squez J, Casta?eda CA, Valencia G, Morante Z, Calder?n M, Abugattas JE, G?mez H, Fuentes HA, Liendo-Picoaga R, Cotrina JM, Monge C, Neciosup SP, Huntsman S, Hu D, S?nchez SE, Williams MA, N??ez-Marrero A, Godoy L, Hechmer A, Olshen AB, Dutil J, Ziv E, Zabaleta J, Gelaye B, V?squez J, G?lvez-Nino M, Enriquez-Vera D, Vidaurre T, Fejerman L. Association between Ancestry-Specific 6q25 Variants and Breast Cancer Subtypes in Peruvian Women. Cancer Epidemiol Biomarkers Prev. 2022 08 02; 31(8):1602-1609.
-
Moore J, Pal T, Beeghly-Fadiel A, Fadden MK, Munro HM, Dujon SA, Reid S, Tezak A, Blasingame M, Ware J, Blot WJ, Shu XO, Zheng W, Sanderson M, Lipworth L. A pooled case-only analysis of obesity and breast cancer subtype among Black women in the southeastern United States. Cancer Causes Control. 2022 Apr; 33(4):515-524.
-
Sarink D, White KK, Loo LWM, Wu AH, Wilkens LR, Le Marchand L, Park SY, Setiawan VW, Merritt MA. Racial/ethnic differences in postmenopausal breast cancer risk by hormone receptor status: The multiethnic cohort study. Int J Cancer. 2022 01 15; 150(2):221-231.
-
Khorram O, Chuang TD. Fibroid stiffness: a cellular modulator of progesterone receptor signaling. Fertil Steril. 2021 07; 116(1):91.
-
Sanderson M, Pal T, Beeghly-Fadiel A, Fadden MK, Dujon SA, Clinton C, Jimenez C, Davis J, Fortune M, Thompson J, Benson K, Conley N, Reid S, Tezak A, Shu XO, Zheng W, Blot WJ, Lipworth L. A Pooled Case-only Analysis of Reproductive Risk Factors and Breast Cancer Subtype Among Black Women in the Southeastern United States. Cancer Epidemiol Biomarkers Prev. 2021 07; 30(7):1416-1423.
-
Wu AH, Franke AA, Wilkens LR, Tseng C, Conroy SM, Li Y, Polfus LM, De Rouen M, Caberto C, Haiman C, Stram DO, Le Marchand L, Cheng I. Urinary phthalate exposures and risk of breast cancer: the Multiethnic Cohort study. Breast Cancer Res. 2021 04 06; 23(1):44.